West Pharmaceutical Services
$365.01Change from previous close: −1.55%Absolute change: −$5.75
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $25.69B
- Enterprise value
- $25.57B
- P/E (trailing 12 months)
- 46.8
- Forward P/E
- 36.6
- PEG
- 2.89
- Price/book
- 8.59
- Price/sales
- 7.72
- EV/EBITDA
- 28.0
- EV/revenue
- 7.69
Profitability and growth
- Gross margin
- 36.8%
- Operating margin
- 22.5%
- Net margin
- 17.0%
- ROE
- 19.1%
- ROA
- 11.4%
- Revenue growth (year over year)
- 13.8%
- Earnings growth (year over year)
- 18.1%
Financial health
- Total cash
- $435.8M
- Total debt
- $316.5M
- Debt/equity
- 0.11
- Current ratio
- 2.82
- Quick ratio
- 1.82
Dividends
- Annual dividend per share
- $0.88
- Dividend yield
- 0.2%
- Payout ratio
- 11.1%
- Ex-dividend date
- July 29, 2026
Analysts and estimates
- Average price target
- $407.56
- Median price target
- $410.00
- High price target
- $459.00
- Low price target
- $340.00
- Analysts with a price target
- 16
- Consensus
- Strong buy
- Forward EPS
- $9.98
- EPS estimate, current year
- $8.96
Shares and trading
- Beta
- 1.14
- Average volume
- 642.82K
- Shares outstanding
- 70.38M
- Float
- 69.85M
- Institutional ownership
- 101.9%
- Insider ownership
- 0.7%
- Short interest (% of float)
- 4.0%
- Short ratio (days)
- 4.89